We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
115 Combination-therapy with neutralizing cyclopeptides and beta-blockers decreases molecular markers of sympathetic activation and reverses cardiomyopathy in beta1-receptor antibody-induced heart failure
- Authors
Boivin, V.; Palm, D.; Frost, R.J.; Hein, L.; Angermann, C.E.; Ertl, G.; Lohse, M.J.; Jahns, R.
- Abstract
An abstract of the study "Combination-Therapy With Neutralizing Cyclopeptides and Beta-Blockers Decreases Molecular Markers of Sympathetic Activation and Reverses Cardiomyopathy in Beta1-Receptor Antibody-Induced Heart Failure," by S. Nodari and colleagues is presented.
- Subjects
CYCLIC peptides; CARDIOMYOPATHIES
- Publication
European Journal of Heart Failure. Supplements, 2007, Vol 6, p28
- ISSN
1567-4215
- Publication type
Abstract
- DOI
10.1016/S1567-4215(07)60075-7